Skip to main content

alza 18 (Methylphenidate Hydrochloride Extended-Release 18 mg)

Pill with imprint alza 18 is Yellow, Capsule-shape and has been identified as Methylphenidate Hydrochloride Extended-Release 18 mg. It is supplied by Watson Pharmaceuticals.

Methylphenidate is used in the treatment of adhd; narcolepsy; depression and belongs to the drug class CNS stimulants. Risk cannot be ruled out during pregnancy. Methylphenidate 18 mg is classified as a Schedule 2 controlled substance under the Controlled Substance Act (CSA).

Images for alza 18

Methylphenidate Hydrochloride Extended-Release

Imprint
alza 18
Strength
18 mg
Color
Yellow
Shape
Capsule-shape
Availability
Prescription only
Drug Class
CNS stimulants
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
2 - High potential for abuse
Labeler / Supplier
Watson Pharmaceuticals
Inactive Ingredients
butylated hydroxytoluene, carnauba wax, cellulose acetate, phosphoric acid, sodium chloride, propylene glycol, stearic acid, succinic acid, ferrosoferric oxide, titanium dioxide, triacetin

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC Code Labeler / Repackager
00591-2715 (Discontinued) Watson Pharmaceuticals, Inc.
50458-0585 Ortho-McNeil Pharmaceutical, LLC
68084-0890 (Discontinued) Amerisource Health Services
54868-4489 (Discontinued) Physicians Total Care Inc. (repackager)
55289-0835 PDRX Pharmaceuticals Inc. (repackager)

Get help with Imprint Code FAQs.

Related images for "alza 18"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.